Literature DB >> 14638768

Resistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactions.

Simon Babayan1, Marie-Noëlle Ungeheuer, Coralie Martin, Tarik Attout, Elodie Belnoue, Georges Snounou, Laurent Rénia, Masataka Korenaga, Odile Bain.   

Abstract

In order to understand natural resistance to filariasis, we compared Litomosoides sigmodontis primary infection of C57BL/6 mice, which eliminate the worms before patency, and BALB/c mice, in which worms complete their development and produce microfilariae. Our analysis over the first month of infection monitoredmigration of the infective larvae from the lymph nodes to the pleural cavity, where the worms settle. Although immune responses from the mouse strains differed from the outset, the duration of lymphatic migration (4 days) and filarial recovery rates were similar, thus confirming that the proportion of larvae that develop in the host species upon infection is not influenced by host genetic variability. The majority of worms reached the adult stage in both mouse strains; however, worm growth and molting were retarded in resistant C57BL/6 mice. Surprisingly, the only immune responses detected at 60 h postinfection occurred in the susceptible mice and only upon stimulation of cells from lymph nodes draining the inoculation site with infective larva extract: massive production of interleukin-6 (IL-6) and IL-5 (the latter cytokine was previously suspected to have an effect on L. sigmodontis growth). However, between days 10 and 30 postinfection, extraordinarily high levels of type 1 and type 2 cytokines and expansion of pleural leukocyte infiltration were seen in the resistant C57BL/6 mice, explaining the destruction of worms later. Our results suggest that events early in the infection determine susceptibility or resistance to subsequent microfilarial production and a parasite strategy to use specific immune responses to its own benefit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638768      PMCID: PMC308919          DOI: 10.1128/IAI.71.12.6820-6829.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.

Authors:  Achim Hoerauf; Norbert Brattig
Journal:  Trends Parasitol       Date:  2002-01

Review 2.  Animal models in the study of the phenomenon of parasitism: filariae and other parasites.

Authors:  O Bain; M Philipp
Journal:  Ann Parasitol Hum Comp       Date:  1991

3.  The Xid defect imparts susceptibility to experimental murine filariosis--association with a lack of antibody and IL-10 production by B cells in response to phosphorylcholine.

Authors:  K M Al-Qaoud; B Fleischer; A Hoerauf
Journal:  Int Immunol       Date:  1998-01       Impact factor: 4.823

4.  Interleukin-4 is essential for the control of microfilariae in murine infection with the filaria Litomosoides sigmodontis.

Authors:  L Volkmann; M Saeftel; O Bain; K Fischer; B Fleischer; A Hoerauf
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni.

Authors:  I Wolowczuk; S Nutten; O Roye; M Delacre; M Capron; R M Murray; F Trottein; C Auriault
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Interleukin-4 influences the production of microfilariae in a mouse model of Brugia infection.

Authors:  Eileen Devaney; Victoria Gillan; Isla Wheatley; Jessica Jenson; Richard O'Connor; Paul Balmer
Journal:  Parasite Immunol       Date:  2002-01       Impact factor: 2.280

7.  Murine filariasis: interleukin 4 and interleukin 5 lead to containment of different worm developmental stages.

Authors:  Lars Volkmann; Odile Bain; Michael Saeftel; Sabine Specht; Kerstin Fischer; Frank Brombacher; Klaus I Matthaei; Achim Hoerauf
Journal:  Med Microbiol Immunol       Date:  2002-12-10       Impact factor: 3.402

8.  Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.

Authors:  L H Elson; M Calvopiña; W Paredes; E Araujo; J E Bradley; R H Guderian; T B Nutman
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

9.  Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals.

Authors:  D J Ward; T B Nutman; G Zea-Flores; C Portocarrero; A Lujan; E A Ottesen
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

10.  Circulating parasite antigen(s) in lymphatic filariasis: use of monoclonal antibodies to phosphocholine for immunodiagnosis.

Authors:  R B Lal; R S Paranjape; D E Briles; T B Nutman; E A Ottesen
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

View more
  28 in total

Review 1.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  The central adaptor molecule TRIF influences L. sigmodontis worm development.

Authors:  Anna Wiszniewsky; Manuel Ritter; Vanessa Krupp; Sandy Schulz; Kathrin Arndts; Heike Weighardt; Samuel Wanji; Achim Hoerauf; Laura E Layland
Journal:  Parasitol Res       Date:  2019-01-15       Impact factor: 2.289

3.  Increased early local immune responses and altered worm development in high-dose infections of mice susceptible to the filaria Litomosoides sigmodontis.

Authors:  Simon Babayan; Tarik Attout; Sabine Specht; Achim Hoerauf; Georges Snounou; Laurent Rénia; Masataka Korenaga; Odile Bain; Coralie Martin
Journal:  Med Microbiol Immunol       Date:  2004-08-26       Impact factor: 3.402

4.  Filarial parasites develop faster and reproduce earlier in response to host immune effectors that determine filarial life expectancy.

Authors:  Simon A Babayan; Andrew F Read; Rachel A Lawrence; Odile Bain; Judith E Allen
Journal:  PLoS Biol       Date:  2010-10-19       Impact factor: 8.029

5.  Basophils help establish protective immunity induced by irradiated larval vaccination for filariasis.

Authors:  Marina N Torrero; C Paul Morris; Blima K Mitre; Marc P Hübner; Ellen M Fox; Hajime Karasuyama; Edward Mitre
Journal:  Vaccine       Date:  2013-06-15       Impact factor: 3.641

6.  Effect of Brugia pahangi co-infection with Plasmodium berghei ANKA in gerbils (Meriones unguiculatus).

Authors:  Olawale Quazim Junaid; Indra Vythilingam; Loke Tim Khaw; Sinnadurai Sivanandam; Rohela Mahmud
Journal:  Parasitol Res       Date:  2020-03-16       Impact factor: 2.289

7.  Litomosoides sigmodontis: a simple method to infect mice with L3 larvae obtained from the pleural space of recently infected jirds (Meriones unguiculatus).

Authors:  Marc P Hübner; Marina N Torrero; John W McCall; Edward Mitre
Journal:  Exp Parasitol       Date:  2009-05-20       Impact factor: 2.011

8.  The chemokine CXCL12 is essential for the clearance of the filaria Litomosoides sigmodontis in resistant mice.

Authors:  Tiffany Bouchery; Gaelle Dénécé; Tarik Attout; Katharina Ehrhardt; Nathaly Lhermitte-Vallarino; Muriel Hachet-Haas; Jean Luc Galzi; Emilie Brotin; Françoise Bachelerie; Laurent Gavotte; Catherine Moulia; Odile Bain; Coralie Martin
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

9.  The human parasite Loa loa in cytokine and cytokine receptor gene knock out BALB/c mice: survival, development and localization.

Authors:  Nicholas Tendongfor; Samuel Wanji; Julius C Ngwa; Mathias E Esum; Sabine Specht; Peter Enyong; Klaus I Matthaei; Achim Hoerauf
Journal:  Parasit Vectors       Date:  2012-02-21       Impact factor: 3.876

10.  Deletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodes.

Authors:  Simon A Babayan; Honglin Luo; Nick Gray; David W Taylor; Judith E Allen
Journal:  PLoS Negl Trop Dis       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.